Clincosm LogoSign in Get a demo

acute myeloid leukemia

Showing 1 - 25 of 1,098
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +3 more
Nov 21, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

Not yet recruiting
  • Acute Myeloid Leukemia
  • MCBC regimen
  • Bu/Cy regimen
  • (no location specified)
Nov 13, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Biospecimen Collection
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Nov 9, 2023

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 27, 2023

    Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL1 and CD38 dual-target CAR-T injection
    • Kunming, Yunnan, China
      920th Hospital of Joint LogisticsSupport Force of People's Liber
    Oct 26, 2023

    Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

    Not yet recruiting
    • Elderly AML Patients
    • +4 more
    • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
    • Active Comparator: Standard dose of Venetoclax + Azacitidine
    • Kunming, Yunnan, China
      The Second Affiliated Hospital of Kunming Medical University.
    Oct 3, 2023

    Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Oral azacitidine
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

    Recruiting
    • Acute Myeloid Leukemia
    • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
    • "3+7"
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Sep 29, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Different induction chemotherapy regimens
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Sep 27, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Duarte, California
    • +1 more
    Sep 22, 2023

    Acute Myeloid Leukemia Trial (Dasatinib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 20, 2023

    Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      Sep 22, 2023

      Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • (no location specified)
      Sep 18, 2023

      Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Sep 18, 2023

      Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myeloid Neoplasm
      • Biospecimen Collection
      • +9 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 5, 2023

      Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • (no location specified)
      Sep 5, 2023

      Acute Myeloid Leukemia Trial in Marseille, Nice (Pharmacokinetic sampling, Vital status determination, Toxicity assessments)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Pharmacokinetic sampling
      • +3 more
      • Marseille, France
      • +1 more
      Sep 6, 2023

      Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Beijing, Beijing, China
        Yuan Kong
      Sep 4, 2023

      Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)

      Not yet recruiting
      • Leukemia
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 28, 2023

      Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Myeloid Leukemia Trial in United States

      Recruiting
      • Refractory Acute Myeloid Leukemia
      • +4 more
      • CD371-YSNVZ-IL18 CAR T cells
      • Basking Ridge, New Jersey
      • +6 more
      Aug 29, 2023

      Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • CD123 targeted CAR-NK cells
      • Taiyuan, Shanxi, China
        Shanxi Bethune Hospital
      Aug 28, 2023